-
- MS Diva
- Sex: F
- Data Quality: 0 stars
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: mild
I have:MSRebif Treatment Evaluation
- Perceived effectiveness for MS (Multiple Sclerosis):
- Side Effects:
- Adherence:
- Burden:
MS Diva added a treatment evaluation for Rebif from Mar 15, 2011 Nov 28, 2011- Advice & Tips
- For me the injection site eslection was the most difficult. Being thin and not having a lot of body fat made finding a place to inject increasingly difficult ovethe coursof the three years I used it.
- Cost
- $50-99 monthly
-
- MS Diva
- Sex: F
- Data Quality: 0 stars
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: mild
I have:MSMS Diva stopped taking the treatment Rebif Nov 28, 2011Stopped: Rebif
- Stopped: Mar 15, 2011
- Reason: Doctor's advice, Personal research, and Side effects too severe
-
- MS Diva
- Sex: F
- Data Quality: 0 stars
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: mild
I have:MSMS Diva updated her symptoms for Nov 28, 2011 Nov 28, 2011Symptom Update
- none Bowel problems
- none Sexual dysfunction
- mild Mood swings
- mild Excessive daytime sleepiness (somnolence)
- mild Insomnia
- mild Brain fog
- See more
-
- MS Diva
- Sex: F
- Data Quality: 0 stars
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: mild
I have:MSMS Diva added the treatment Avonex Prefilled Syringe Nov 28, 2011Avonex Prefilled Syringe
- Started: ?
- Dosage: ?
- Purpose: MS
-
- MS Diva
- Sex: F
- Data Quality: 0 stars
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: mild
I have:MSMS Diva updated the treatment Gilenya Nov 28, 2011Gilenya
- Started: Apr 1, 2011
- Current Dosage: 0.5 mg daily
- Purpose: MS





